Growing investment in personalized medicine is fueling the need for high-quality plasmid DNA. Biopharmaceutical companies are expanding manufacturing capabilities to support clinical and commercial supply. The market is becoming a critical foundation for next-generation therapeutic development. DNA Plasmid Manufacturing Market to Hit US$ 2.65B by 2031 Boom The DNA plasmid manufacturing market...